Skip to content

Clinical trials

Myeloproliferative Disorders trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Country / region: Germany Clear all

54 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20031
20041
20052
20061
20092
20101
20112
20122
20134
20147
20151
20161
20171
20182
20194
20203
20217
20222
20231
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Active, not recruiting11
Terminated9
Recruiting7
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation8
Novartis Pharmaceuticals7
Fred Hutchinson Cancer Center5
European Organisation for Research and Treatment of Cancer - EORTC4
Celgene3
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS3
AbbVie2
CTI BioPharma2
Italfarmaco2
Sierra Oncology LLC - a GSK company2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders54
Primary Myelofibrosis25
Polycythemia Vera17
Thrombocythemia, Essential15
Leukemia, Myeloid, Acute14
Hematologic Diseases13
Bone Marrow Diseases11
Leukemia, Myelomonocytic, Chronic10
Myelodysplastic Syndromes10
Precursor Cell Lymphoblastic Leukemia-Lymphoma10

Trials

Showing 51 to 54 of 54. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.